Two Sigma Securities’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Two Sigma Securities’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-38,606	Closed	-$654K	–	391
2014 Q4	$654K	Buy	+38,606	New	+$543K	0.55%	45

Two Sigma Securities's AVNR Position: Q1 2015 in Review

Two Sigma Securities sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 38,606 shares — an estimated $654K sold.

Two Sigma Securities first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $654K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Two Sigma Securities reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Two Sigma Securities sold 38,606 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $654K.
Two Sigma Securities first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Two Sigma Securities's AVANIR PHARMACEUTICALS, INC CL A position peaked at $654K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Two Sigma Securities's 13F filing for Q1 2015, filed 15 May 2015.